Progress has been made to implement newborn screening (NBS) but few conditions are screened for in most #LATAM countries. Improved processes, patient follow up & consideration for implementation of expanded NBS & other early diagnostic approaches that leverage #Genomics for the accurate diagnosis of #RareDiseases are important to reduce the #DiagnosticOdyssey & improve patient care & outcomes. #RareDisease #ERCAL

Proud to share our latest article on "Opportunities & Challenges for Newborn Screening and Early Diagnosis of Rare Diseases in Latin America" published today in #FrontiersInGenetics

This article is the product of careful review, deep discussion & insightful consensus on the current state and opportunities of newborn screening & early diagnosis approaches in Latin America for the better & accurate diagnosis of #RareDisease patients in #LATAM #ERCAL

https://www.frontiersin.org/articles/10.3389/fgene.2022.1053559/full